All News #Library
Biotech
Genenta Transforms To Saentra Forge, Inks Binding Offer
27 Mar 2026 //
GLOBENEWSWIRE
Genenta Explores Strategic Options For Biotech Platform
24 Mar 2026 //
GLOBENEWSWIRE
Genenta Advances Saentra Forge, Strengthens ATC and Expands
27 Feb 2026 //
GLOBENEWSWIRE
Genenta Transforms Into Biotech And Defense Industry Consolidator
27 Jan 2026 //
GLOBENEWSWIRE
Genenta Shows Long-Term Survival Trends In GBM Trial
24 Nov 2025 //
GLOBENEWSWIRE
Genenta, Anemocyte Partner to Advance LVV DNA Production
24 Oct 2025 //
GLOBENEWSWIRE
Genenta and Anemocyte collaborate on cell therapy materials
07 May 2025 //
GLOBENEWSWIRE
Genenta Showcases Vision at Biotech Forum in Qatar
15 Apr 2025 //
GLOBENEWSWIRE
Genenta, AGC Biologics Strengthen Cell Therapy Manufacturing Pact
09 Jan 2025 //
CONTRACTPHARMA
Genenta Secures Approval for Trial in Metastatic Renal Cell Cancer
02 Oct 2024 //
GLOBENEWSWIRE
Genenta to Provide Update on Lead Product Temferon
16 May 2023 //
GLOBENEWSWIRE
FDA Grants Orphan Drug Designation to Temferon for Glioblastoma Multiforme
02 Mar 2023 //
GLOBENEWSWIRE
Genenta and AGC Biologics Enter Development and Manufacturing Service Agreement
07 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support